BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
BD (NYSE: BDX) has appointed Bilal Muhsin as Executive Vice President and future President of its Connected Care segment, effective July 2, 2025. Muhsin, who will report to CEO Tom Polen, joins from Masimo where he served as COO during his 25-year tenure.
In this newly created role, Muhsin will lead BD's Connected Care strategy, focusing on advanced analytics and AI solutions alongside smart devices to enhance patient care efficiency. The appointment aligns with BD's transformation into a pure-play MedTech leader, emphasizing connected medication management, advanced workflow robotics, and smart monitoring solutions.
Muhsin brings significant expertise in medical engineering and software development, holding over 50 patents in Medical Systems Communication, Analytics, and Patient Monitoring Systems.
BD (NYSE: BDX) ha nominato Bilal Muhsin Vice Presidente Esecutivo e futuro Presidente del segmento Connected Care, a partire dal 2 luglio 2025. Muhsin, che riporterà direttamente al CEO Tom Polen, arriva da Masimo dove ha ricoperto il ruolo di COO durante i suoi 25 anni di carriera.
In questo nuovo ruolo, Muhsin guiderà la strategia di BD nel settore Connected Care, concentrandosi su soluzioni avanzate di analisi e intelligenza artificiale insieme a dispositivi smart per migliorare l'efficienza nell'assistenza ai pazienti. La nomina è in linea con la trasformazione di BD in un leader MedTech puro, con un focus sulla gestione connessa dei farmaci, robotica avanzata per i flussi di lavoro e soluzioni di monitoraggio intelligenti.
Muhsin porta con sé una notevole esperienza nell'ingegneria medica e nello sviluppo software, detenendo oltre 50 brevetti nei campi della comunicazione nei sistemi medici, analisi e sistemi di monitoraggio dei pazienti.
BD (NYSE: BDX) ha nombrado a Bilal Muhsin como Vicepresidente Ejecutivo y futuro Presidente de su segmento Connected Care, con efecto a partir del 2 de julio de 2025. Muhsin, quien reportará al CEO Tom Polen, proviene de Masimo, donde se desempeñó como COO durante sus 25 años de carrera.
En este nuevo puesto, Muhsin liderará la estrategia de Connected Care de BD, enfocándose en soluciones avanzadas de análisis y IA junto con dispositivos inteligentes para mejorar la eficiencia en la atención al paciente. Este nombramiento está alineado con la transformación de BD en un líder MedTech puro, con énfasis en la gestión conectada de medicamentos, robótica avanzada para flujos de trabajo y soluciones inteligentes de monitoreo.
Muhsin aporta una amplia experiencia en ingeniería médica y desarrollo de software, con más de 50 patentes en comunicación de sistemas médicos, análisis y sistemas de monitoreo de pacientes.
BD (NYSE: BDX)는 2025년 7월 2일부로 빌랄 무신을 Connected Care 부문의 최고운영책임자 겸 미래 사장으로 임명했습니다. 무신은 CEO 톰 폴렌에게 보고하며, 25년간 근무한 마시모에서 COO로 일한 경력이 있습니다.
새로 신설된 이 직책에서 무신은 BD의 Connected Care 전략을 이끌며, 환자 치료 효율성을 높이기 위해 고급 분석 및 AI 솔루션과 스마트 기기에 중점을 둘 예정입니다. 이 임명은 BD가 순수 MedTech 리더로 변모하는 과정에서 연결된 약물 관리, 첨단 작업 흐름 로봇 공학, 스마트 모니터링 솔루션에 집중하는 전략과 일치합니다.
무신은 의료 공학 및 소프트웨어 개발 분야에서 풍부한 전문성을 갖추고 있으며, 의료 시스템 통신, 분석 및 환자 모니터링 시스템 분야에서 50개 이상의 특허를 보유하고 있습니다.
BD (NYSE : BDX) a nommé Bilal Muhsin Vice-Président Exécutif et futur Président de sa division Connected Care, à compter du 2 juillet 2025. Muhsin, qui reportera au CEO Tom Polen, rejoint l'entreprise après avoir été COO chez Masimo durant ses 25 années de carrière.
Dans ce nouveau rôle créé pour lui, Muhsin dirigera la stratégie Connected Care de BD, en se concentrant sur les solutions avancées d'analytique et d'IA ainsi que sur les dispositifs intelligents pour améliorer l'efficacité des soins aux patients. Cette nomination s'inscrit dans la transformation de BD en un leader MedTech pur, mettant l'accent sur la gestion connectée des médicaments, la robotique avancée des flux de travail et les solutions de surveillance intelligentes.
Muhsin apporte une expertise significative en ingénierie médicale et développement logiciel, détenant plus de 50 brevets dans les domaines de la communication des systèmes médicaux, de l'analytique et des systèmes de surveillance des patients.
BD (NYSE: BDX) hat Bilal Muhsin zum Executive Vice President und zukünftigen Präsidenten seines Connected Care-Segments ernannt, wirksam ab dem 2. Juli 2025. Muhsin, der direkt an CEO Tom Polen berichten wird, kommt von Masimo, wo er während seiner 25-jährigen Tätigkeit als COO tätig war.
In dieser neu geschaffenen Position wird Muhsin die Connected Care-Strategie von BD leiten, mit Fokus auf fortschrittliche Analytik- und KI-Lösungen sowie intelligente Geräte, um die Effizienz der Patientenversorgung zu verbessern. Die Ernennung steht im Einklang mit BD's Transformation zu einem reinen MedTech-Führer, mit Schwerpunkt auf vernetztem Medikamentenmanagement, fortschrittlicher Workflow-Robotik und intelligenten Überwachungslösungen.
Muhsin bringt umfangreiche Expertise in medizinischer Technik und Softwareentwicklung mit und hält über 50 Patente in den Bereichen medizinische Systemkommunikation, Analytik und Patientenüberwachungssysteme.
- Strategic appointment of experienced executive with 25 years in healthcare technology
- Focus on AI and advanced analytics positions BD for digital healthcare transformation
- Appointment supports BD's strategic transition to pure-play MedTech leadership
- New leader brings strong innovation credentials with over 50 patents
- None.
Under Bilal's leadership, BD Connected Care will aim to leverage advanced analytics and AI solutions alongside BD's industry-leading smart devices to improve the efficiency and effectiveness of patient care while driving compelling growth opportunities in new areas of health care, such as connected medication management, advanced workflow robotics and smart monitoring solutions. In this newly created role, Muhsin will be responsible for advancing BD's future Connected Care strategy, including shaping organizational capabilities, driving and executing the commercial strategy, accelerating industry-leading innovation initiatives, and ensuring operational and quality excellence.
"With his extensive and deep knowledge of connected care technologies, software and informatics strategies, combined with his intense focus on the customer, Bilal will have a profound impact at BD as we advance our connected care strategy with cutting-edge, AI-driven technology that transforms patient care by improving safety, efficiency and outcomes," said Polen. "This is another step forward in advancing our New BD strategy as a differentiated, pure-play MedTech leader, and Bilal will play a critical role in helping BD accelerate our growth and impact on healthcare by capitalizing on the significant digital, robotic and AI technology innovation that we are so well-positioned to capitalize on."
Muhsin joins BD from Masimo, a health technology and consumer electronics manufacturer, where he spent 25 years, most recently as chief operating officer. Prior to that, Bilal held several other leadership roles at Masimo, including executive vice president of engineering, marketing and regulatory. Muhsin has decades of experience with a proven track record in medical engineering and software development, and holds more than 50 patents in Medical Systems Communication, Analytics and Patient Monitoring Systems.
Muhsin holds a Bachelor of Science degree in Computer Science from San Diego State University.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
BD Corporate Communications | BD Investor Relations |
201.258.0361 | 201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-appoints-bilal-muhsin-as-executive-vice-president-and-president-of-future-connected-care-segment-302499228.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
Who is the new Connected Care segment president at BD (BDX)?
What is Bilal Muhsin's background before joining BD (BDX)?
What will be Bilal Muhsin's responsibilities at BD (BDX)?
How does this appointment align with BD's (BDX) strategy?
Who will Bilal Muhsin report to at BD (BDX)?
